Erlotinib Completed Phase 1 Trials for Metastatic Solid Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00611468Phase I, Dosage-finding and PK Study of IV Topotecan and Erlotinib With Refractory Solid Tumors